Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition

TAK-475 (lapaquistat acetate) and its active metabolite-I (TAK-475 M-I) inhibit squalene synthase, which catalyzes the conversion of farnesyl diphosphate (FPP) to squalene. FPP is a substrate for synthesis of other mevalonate-derived isoprenoids (MDIs) such as farnesol (FOH), geranlygeranyl diphosph...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Nobutaka, Ito, Tatsuo, Matsui, Hisanori, Takizawa, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005254/
https://www.ncbi.nlm.nih.gov/pubmed/27652005
http://dx.doi.org/10.1186/s40064-016-3125-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005254/
https://www.ncbi.nlm.nih.gov/pubmed/27652005
http://dx.doi.org/10.1186/s40064-016-3125-1

Ejemplares similares